US Patent Issued to ADICET THERAPEUTICS on July 28 for "Compositions and methods regarding engineered and non-engineered Gamma Delta T-cells for treatment of hematological tumors" (California Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,319, issued on July 28, was assigned to ADICET THERAPEUTICS INC. (Redwood City, Calif.).

"Compositions and methods regarding engineered and non-engineered Gamma Delta T-cells for treatment of hematological tumors" was invented by Daulet Kadyl Satpayev (Menlo Park, Calif.), Marissa Ann Herrman (Menlo Park, Calif.), Jason Michael Romero (Menlo Park, Calif.), Yifeng Frank Jing (Menlo Park, Calif.), Zili An (Menlo Park, Calif.) and Aya Jakobovits (Menlo Park, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Aspects of the invention include compositions and methods for treatment of hematological tumors with engineered or non-engineered GammaDelta-T ...